RxDoctor Payments Data

Juno Choe

Radiation Oncology · Kennewick, WANPI 1700099439

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,500 of the $11,174 with a category attached, or 76.1%. Novocure Inc. accounts for 79.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $5,384 and has fallen 79.4% since, to $1,111 in 2025. Among radiation oncology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,174in general payments, 2019–2025

Across 57 payments — averaging $196.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$9K
  • Boston Scientific$796
  • Elekta, Inc.$306
  • Stryker$172
  • Intuitive Surgical$128
  • Progenics Pharmaceuticals, Inc.$127
  • plus $811 from 17 others

What the payments were for

  • Consulting fees$8,50076%
  • Food & beverage$2,67424%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,174 in reported general payments places this provider in the 90th percentile of 168 radiation oncology providers in Washington.

See all radiation oncology providers in Washington

Medicare billing

Part B allowed, 2024
$1,656,631
Medicare patients
479
Services billed
7,389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl207$2,725
Oxycodone Hcl17$262
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$171
Megestrol Acetate17$126
Ciprofloxacin Hcl34$92
Bicalutamide13$79
Lorazepam29$28

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Kennewick

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →